Cargando…
RadWise: A Rank-Based Hybrid Feature Weighting and Selection Method for Proteomic Categorization of Chemoirradiation in Patients with Glioblastoma
SIMPLE SUMMARY: Glioblastoma (GBM) is a type of primary brain cancer that is extremely aggressive and almost always fatal. To examine the response to treatment and classify GBM non-invasively, researchers are turning to proteome analysis to identify protein biomarkers associated with interventions....
Autores principales: | Tasci, Erdal, Jagasia, Sarisha, Zhuge, Ying, Sproull, Mary, Cooley Zgela, Theresa, Mackey, Megan, Camphausen, Kevin, Krauze, Andra Valentina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216128/ https://www.ncbi.nlm.nih.gov/pubmed/37345009 http://dx.doi.org/10.3390/cancers15102672 |
Ejemplares similares
-
GradWise: A Novel Application of a Rank-Based Weighted Hybrid Filter and Embedded Feature Selection Method for Glioma Grading with Clinical and Molecular Characteristics
por: Tasci, Erdal, et al.
Publicado: (2023) -
SDPS-29 SERUM-DERIVED CD47 AS A MARKER OF TUMOR BURDENAND OUTCOME IN GBM PATIENTS – CORRELATIVE ANALYSISOF TUMOR LOCATION, RADIATION THERAPY VOLUMES,AND SURVIVAL
por: Jagasia, Sarisha, et al.
Publicado: (2023) -
Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma—Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation
por: Krauze, Andra V., et al.
Publicado: (2023) -
Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panel
por: Krauze, Andra Valentina, et al.
Publicado: (2023) -
Cost Matrix of Molecular Pathology in Glioma—Towards AI-Driven Rational Molecular Testing and Precision Care for the Future
por: Jagasia, Sarisha, et al.
Publicado: (2022)